Investing
HSS announced it raised $21 million in Series A funds to launch the new company.
Noala, Elion and Upheal also announced funding rounds.
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
During a discussion at the Frontiers Health Global Hybrid Conference, panelists said a more competitive funding environment could push startups and investors to focus on quality.
Genomic testing company Variantyx raised $20 million in debt financing, and mental health provider Mindful Care scooped up $7 million.
The company will use the funds to expand its platform and accelerate global commercialization.
The company will expand its network and platform and increase R&D investments.
The virtual care startup for LGBTQ+ patients will also use the investment to expand its recently launched enterprise offering.
The company announced a $10 million Series B raise last year.
The startup said it will use the Series A funds to continue developing its software.